ACADIA PHARMACEUTICALS INC (ACAD) Return on equity 2016–2025
ACADIA PHARMACEUTICALS INC (ACAD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
31.9%FY2025 · since FY2016: -52.4% → 31.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 31.9% | +1.0 pp |
| FY2024 | 30.8% | +45.0 pp |
| FY2023 | -14.1% | +39.3 pp |
| FY2022 | -53.4% | -22.4 pp |
| FY2021 | -31.1% | +13.8 pp |
| FY2020 | -44.9% | -11.3 pp |
| FY2019 | -33.7% | +17.5 pp |
| FY2018 | -51.2% | +35.1 pp |
| FY2017 | -86.3% | -34.0 pp |
| FY2016 | -52.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice